ID | 1239 |
Name of the vaccine | GX-70 |
Microbe | Bacteria |
Disease name | Pulmonary Tuberculosis (TB) |
Name of bacteria | Mycobacterium tuberculosis |
Type of vaccine | DNA vaccine |
Nucleic acid content | DNA |
Age | 19 to 65 years |
Description of the vaccine | DNA-based therapeutic vaccine. |
Name of the manufacturer | Yonsei University |
Name of the manufacturing country | NA |
Year of manufacture | 2018 |
Clinical Phase status | Clinical - Withdrawn |
Bacterial strain | Acid-fast Gram-positive bacteria. |
Efficacy | NA |
Vaccine formulation | NA |
Dosage | Different dose levels given every 4 weeks 5 times. |
Mechanism of action | NA |
Route of administration | Intramuscular |
Indications | NA |
Export | NA |
Approval | NA |
Adjuvant | NA |
Repurposing | For high risk factors for relapse and treatment failure. |
Side effects of vaccine | NA |
Post vaccination | NA |
Dose type | Combination doses |
Interspecies transfer | NA |
PubMed identifier | NA |
Clinical trial number | NCT03159975 |
Reference | NA |
Other name | NA |
Additional Links | NA
|